Clinical Study of Pregnant Women With COVID-19

Clinical Study of Pregnant Women With COVID-19: A Retrospective Review of Medical Records at Strasbourg University Hospitals

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04701944

Acronym

PregWom-Covid

Enrollment

Registered

2021-01-08

Start date

2020-04-21

Completion date

2021-04-21

Last updated

2021-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19

Keywords

COVID-19, COVID-19 Pandemic, Sars-cov-2, Pregnant women

Brief summary

A new pandemic, COVID-19, has spread rapidly around the world. She does not spare pregnant women. Little is known about the clinical course of pregnant women infected with COVID-19. As of April 1, 2020, six case series and one case report for a total of 61 pregnancies affected by COVID-19, all from the pandemic epicenter in China, except for one state case report -Unis, have been published. These preliminary reports suggest that pregnant women are not more seriously affected than the general population and show a certain gap with what we have observed in the care of pregnant women at HUS. For these reasons, additional information, especially from parts of the world other than China, as the severity of the disease can vary from country to country, is urgently needed to determine whether pregnant women with the disease of COVID-19 will not present with severe pneumonia to COVID-19.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Inclusion criteria

* Adult woman (≥18 years old) * Pregnant woman * Suffering from a confirmed or suspected COVID-19 infection * Patient who has been medically treated at Strasbourg University Hospitals as well as for his newborn baby, between 03/01/2020 and April 30, 2020 * Woman having given, after information, her agreement for the reuse of her data for the purposes of this research

Exclusion criteria

* Patient who expressed her opposition to participating in the study * Patient under guardianship or under guardianship * Patient under legal protection

Design outcomes

Primary

Measure	Time frame
A retrospective review of the medical records of pregnant women with COVID-19 at the University Hospitals of Strasbourg	Files analysed retrospectively from March 01, 2020 to April 30, 2020 will be examined]

Countries

France

Contacts

Primary ContactPhilippe DERUELLE, MD, PhD

philippe.deruelle@chru-strasbourg.fr33 3 88 12 84 55

Backup ContactSaïd CHAYER, PhD, HDR

said.chayer@chru-strasbourg.fr33 3 88 11 66 90

Outcome results